Supplementary Figure S3 from Safety and clinical response to combined immunotherapy with autologous iNKT cells and PD-1+CD8+ T cells in patients failing first-line chemotherapy in stage IV pancreatic cancer

Gating strategy to detect CD4+ T, CD8+ T, B and NK cells by flow cytometry. Only living cells were included in the analysis (A). Changing in percentages of CD4+ T, CD8+ T, B, and NK cells during treatment are shown in panels B, C, D and E respectively.